Botensilimab,balstilimab
agenus
[]
encouraging response rates with bot and bal among patients with msi-s refractory colon cancer! congratulations and team! there is hope for immunotherapy for msi-s tumors still. #gi23
Medical Director, GI Oncology Program - AdventHealth Cancer Institute. Passionate about clinical research, education and pt-prov communication. #gicancer #meded